RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS

by I. A. Burmistrova, A. G. Samoylova, K. A. Glebov, A. E. Panova, T. S. Radina, I. A. Vasilyeva
Published 2019-01-01

COVERAGE WITH TESTS AND FREQUENCY OF MULTIPLE/EXTENSIVE DRUG RESISTANT TUBERCULOSIS IN THE CIVILIAN HEALTH SERVICES AND PENITENTIARY SYSTEM

by V. V. Testov, S. A. Sterlikov, I. A. Vasilieva, Yu. V. Tikhonova, K. A. Glebov, A. E. Panova
Published 2019-07-01

Drug resistance pattern of <i>M. tuberculosis</i> in those who developed the disease after exposure to MDR/XDR pulmonary tuberculosis

by K. A. Glebov, V. A. Guseva, I. A. Burmistrova, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva
Published 2020-01-01

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE

by I. A. Vasilyeva, A. G. Samoylova, A. V. Rudakova, O. V. Lovacheva, K. A. Glebov, L. N. Chernousova
Published 2018-07-01

Prevalence of tuberculosis with multiple and extensive drug resistance according to the data of Federal register of tb cases

by V. V. Testov, I. A. Vasilyeva, S. A. Sterlikov, I. D. Medvinskiy, K. A. Glebov, E. G. Аntonova, E. D. Filina, I. A. Sidorova
Published 2020-01-01